Turn Therapeutics (TTRX) Free Cash Flow (2024 - 2026)

Turn Therapeutics' Free Cash Flow history runs 3 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 436.81% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$3.1 million (changed N/A YoY), while the FY2025 annual figure was -$2.6 million, down 88.27% from the prior year.
• Free Cash Flow was -$1.6 million for Q1 2026 at Turn Therapeutics, down from -$1.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$298058.0 in Q1 2025 to a low of -$1.6 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$875376.0 across 3 years, with a median of -$801723.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow sank 172.42% in 2025, then tumbled 436.81% in 2026.
• A 3-year view of Free Cash Flow shows it stood at -$430545.0 in 2024, then sank by 172.42% to -$1.2 million in 2025, then sank by 36.41% to -$1.6 million in 2026.
• The last three Free Cash Flow figures came in at -$1.6 million (Q1 2026), -$1.2 million (Q4 2025), and -$298058.0 (Q1 2025), per Business Quant data.